T1	Pharmacokinetic_phenotype	69 117	area under the plasma concentration-time curve (
T2	Pharmacodynamic_phenotype	145 169	plasma concentration ( C
T3	Pharmacodynamic_phenotype	178 201	) of tacrolimus between
T4	Limited_variation	202 225	CYP2C19 genotype groups
T5	Limited_variation	275 298	CYP3A5 genotypes groups
T6	Chemical	504 514	azole ( 74
T7	Chemical	515 535	5 34 0 vs. 52 4 27 4
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T1	Arg2:T7
R7	isAssociatedWith	Arg1:T2	Arg2:T1
R8	isAssociatedWith	Arg1:T2	Arg2:T3
R9	isAssociatedWith	Arg1:T2	Arg2:T4
R10	isAssociatedWith	Arg1:T2	Arg2:T5
R11	isAssociatedWith	Arg1:T2	Arg2:T6
R12	isAssociatedWith	Arg1:T2	Arg2:T7
R13	isAssociatedWith	Arg1:T3	Arg2:T1
R14	isEquivalentTo	Arg1:T3	Arg2:T2
R15	isAssociatedWith	Arg1:T3	Arg2:T4
R16	isAssociatedWith	Arg1:T3	Arg2:T5
R17	isAssociatedWith	Arg1:T3	Arg2:T6
R18	isAssociatedWith	Arg1:T3	Arg2:T7
R19	influences	Arg1:T4	Arg2:T1
R20	influences	Arg1:T4	Arg2:T2
R21	influences	Arg1:T4	Arg2:T3
R22	influences	Arg1:T4	Arg2:T5
R23	influences	Arg1:T4	Arg2:T6
R24	influences	Arg1:T4	Arg2:T7
R25	influences	Arg1:T5	Arg2:T1
R26	influences	Arg1:T5	Arg2:T2
R27	influences	Arg1:T5	Arg2:T3
R28	influences	Arg1:T5	Arg2:T4
R29	influences	Arg1:T5	Arg2:T6
R30	influences	Arg1:T5	Arg2:T7
R31	influences	Arg1:T6	Arg2:T1
R32	influences	Arg1:T6	Arg2:T2
R33	influences	Arg1:T6	Arg2:T3
R34	isAssociatedWith	Arg1:T6	Arg2:T4
R35	isAssociatedWith	Arg1:T6	Arg2:T5
R36	isAssociatedWith	Arg1:T6	Arg2:T7
R37	isAssociatedWith	Arg1:T7	Arg2:T1
R38	isAssociatedWith	Arg1:T7	Arg2:T2
R39	isAssociatedWith	Arg1:T7	Arg2:T3
R40	isAssociatedWith	Arg1:T7	Arg2:T4
R41	isAssociatedWith	Arg1:T7	Arg2:T5
R42	isAssociatedWith	Arg1:T7	Arg2:T6
